BUSINESS UNITS / Generics API
We are making a difference with affordable and high-quality APIs manufactured with the highest
Building on our strong capabilities in chemical development and manufacturing, Laurus Labs
has developed a wide range of in-house APIs and intermediates. We focus on chemistry
where we can make a difference and combine innovation with efficiency to develop
cost-effective and hence affordable processes. We regularly invest in building capacities to
ensure reliable and sustained supply.
Laurus is one of the world’s leading suppliers of anti-retroviral APIs and intermediates.
Our low-cost technologies in this critical segment are helping increase access to affordable
medicine for patients around the world. We work closely with leading innovators, global health
and providers to meet cost reduction targets, without compromising quality standards.
Oncology is one of our core competencies. We offer a comprehensive range of APIs
in this segment. Our state-of-the-art facilities are capable of handling high-potent materials
at both development and commercial scale. Laurus is continuously extending its portfolio by
focusing on molecules in diabetes, ophthalmology,
and cardio-vascular therapy areas, where we can make a difference and establish a leadership
We offer our globally compliant cGMP facilities, along with our chemistry expertise,
to customers for contract development and manufacturing of APIs and intermediates. We are
a preferred CRAMs partner to several customers, owing to our stringent quality and EHS systems,
wide operability range (from grams to multi-tonnage scale), robust project management practices,
and vast contract manufacturing experience. With proven capabilities, we provide an end-to-end
API solutions to global markets
that meet and exceed the quality, regulatory and IP requirements as well as cost targets.